Table 3.
Outcomes | Total (N = 187) | PCR positive (N = 10) | PCR negative (N = 177) | P |
---|---|---|---|---|
IgG positive, N (%) | 154 | 8 (80.0) | 146 (82.4) | 0.999 |
IgM positive, N (%) | 35 | 2 (20.0) | 33 (18.6) | 0.999 |
First antibody tests from onset, day | 53.0 ± 9.9 | 50.3 ± 16.5 | 53.2 ± 9.4 | 0.369 |
Follow-up time, day | 45.7 ± 11.2 | 48.7 ± 11.7 | 45.5 ± 11.1 | 0.380 |
Re-infected, N | 0 | 0 | 0 | N/A |
Fever during follow-up, N | 0 | 0 | 0 | N/A |
Transmission after discharge, N | 0 | 0 | 0 | N/A |
Reported by the cured, N | 0 | 0 | 0 | N/A |
Reported by CDC, N | 0 | 0 | 0 | N/A |
Contact with newly diagnosed patients, N | 0 | 0 | 0 | N/A |
PCR, polymerase chain reaction; CDC, Centers for Disease Control and Prevention.